Multivariate analysis identified FIB-4 score ≥3.25 and AFP level >6 ng/ml after DAA treatment as independent factors that contributed to the development of HCC in patients without cirrhosis (S5 and S6 Tables). This evidence concerns the gene AFP and hepatocellular carcinoma.